𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting of T lymphocytes against egf-receptor+ tumor cells by bispecific monoclonal antibodies: Requirement of CD3 molecule cross-linking for t-cell activation

✍ Scribed by Silvano Ferrini; Anna Cambiaggi; Sabrina Sforzini; Sabrina Marciano; Silvana Canevari; Delia Mezzanzanica; Maria Ines Colnaghi; Carlo Enrico Grossi; Lorenzo Moretta


Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
835 KB
Volume
55
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Retargeting of T-cell-receptor gamma/del
✍ Silvano Ferrini; Ignazia Prigione; Serafina Mammoliti; Maria Ines Colnaghi; Sylv πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 307 KB

We have recently selected MAbs specific for different molecular forms of the TCR gammddelta (expressed by distinct cell subsets), able to activate TCR gamma/delta+ cells. Two of these reagents (GI and Al3) were used for the construction of bispecific MAbs in conjunction with a MAb (Mov 19) directed

The role of lymphocyte subsets and adhes
✍ Christoph Renner; Wolfram Jung; Ugur Sahin; Rene van Lier; Michael Pfreundschuh πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 776 KB

## Abstract The cure of human Hodgkin's tumors heterotransplanted into SCID mice can be achieved by two bispecific monoclonal antibodies (Bi‐mAb) directed against the tumor‐associated CD30 antigen and CD3 and CD28, respectively, and normal peripheral human blood T cells. We investigated the role of